Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Welcoming Our Newest IPC Councilors: Leaders in Psoriasis Treatment and Research

Join us in welcoming IPC’s newest Councilors: Christopher Bunick, Jeffrey Cohen, Giovanni Damiani, Victoria Guillano, Renata Magalhães, Eingun James Song, and Yi Xiao. Recently appointed and selected by the IPC Board of Directors, these experts are dedicated to enhancing global research on psoriasis and improving patient care.

As IPC Councilors, they will leverage their expertise to advance IPC initiatives in research, treatment, and education on a global scale, aligning with our commitment to improving the health and well-being of people with psoriasis worldwide. We invite you to learn more about these psoriasis experts through their biographies and discover how they contribute to our mission of enhancing patient outcomes and empowering health care professionals.

Let’s warmly welcome Christopher Bunick, Jeffrey Cohen, Giovanni Damiani, Victoria Guillano, Renata Magalhães, Eingun James Song, and Yi Xiao as they join the IPC Councilor community. Their addition underscores IPC’s commitment to driving positive change and improving global psoriasis care.

Christopher Bunick, MD, PhD

Yale University

New Haven, Connecticut, United States

IPC Councilor

Bio

Jeffrey Cohen, MD, MPH

Yale School of Medicine

New Haven, Connecticut, United States

IPC Councilor

Bio

Giovanni Damiani, MD, PhD

University of Milan

Milan, Italy

IPC Councilor

Bio

Victoria Patiño-Guillano, MD, FPDS, FDSP-PDS, MBA-H

University of Southeastern Philippines; DermPath Dermatology

Tagum, Philippines

IPC Councilor

Bio

Renata Ferreira Magalhães, MD, PhD

Unicamp Clinical Hospital

Campinas, Brazil

IPC Councilor

Bio

Eingun James Song, MD, FAAD

Frontier Dermatology

Mill Creek, Washington, United States

IPC Councilor

Bio

Yi Xiao, MD, PhD, MPH

Department of Dermatology, Xiangya Hospital, Central South University

Changsha, China

IPC Councilor

Bio

Comments are closed.

Categories

Recent Posts

Highlights from the 2026 European Academy of Dermatology and Venereology (EADV) Congress: Personalized Medicine, Therapeutic Advances, and Late-Breaking Research

What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline

When Cancer and Psoriasis Coexist: New IPC Guidance Puts Clarity Where It Is Needed Most

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026